115 related articles for article (PubMed ID: 7036282)
1. Adjuvant intermittent chemoimmunotherapy for primary breast cancer: a prospective study with immunologic follow-up.
Betzler M; Schreml W; Lang M; Lohrmann HP; Flad HD; Schlag P; Herfarth C; Heimpel H
Recent Results Cancer Res; 1982; 80():185-91. PubMed ID: 7036282
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative and functional response of a lymphatic subpopulation during adjuvant intermittent chemo-immunotherapy in breast cancer].
Betzler M; Flad HD; Huget R; Schreml W; Schlag P; Herfarth C
Chir Forum Exp Klin Forsch; 1978; (1978):227-30. PubMed ID: 313321
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant intermittent chemo-immunotherapy of breast cancer. A prospective study.
Schreml W; Betzler M; Lang M; Lohrman HP; Kubitza P; Schlag P; Flad HD; Herfarth C; Heimpel H
Eur J Cancer (1965); 1980; Suppl 1():165-8. PubMed ID: 7032927
[No Abstract] [Full Text] [Related]
4. Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
Yap HY; Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Krutchik AN; Benjamin RS; Gutterman JU; Bodey GP
J Surg Oncol; 1979 Dec; 12(4):333-41. PubMed ID: 392197
[TBL] [Abstract][Full Text] [Related]
5. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
Klefström P
Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer.
Gröhn P; Heinonen E; Klefström P; Tarkkanen J
Cancer; 1984 Aug; 54(4):670-4. PubMed ID: 6744203
[TBL] [Abstract][Full Text] [Related]
7. Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
Stephens EJ; Wood HF; Mason B
Recent Results Cancer Res; 1978; 68():139-45. PubMed ID: 379932
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole.
Klefström P; Gröhn P; Heinonen E; Holsti L; Holsti P
Cancer; 1987 Sep; 60(5):936-42. PubMed ID: 3300953
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of levamisole-induced granulocytopenia in breast cancer patients.
Vogel CL; Silverman MA; Mansell PW; Miller AM; Thompson JS; Herbick JM; Brunskill DE; Padgett DC; McKinney EC; Sugarbaker EV
Am J Hematol; 1980; 9(2):171-83. PubMed ID: 6969027
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)--six-year evaluation.
Schreml W; Lang M; Betzler M; Schlag P; Lohrmann HP; Heimpel H; Herfarth C
Eur J Cancer Clin Oncol; 1983 May; 19(5):607-13. PubMed ID: 6683632
[TBL] [Abstract][Full Text] [Related]
11. Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group Trial.
Carpenter JT; Smalley RV; Raney M; Vogel CL; Weiner RS
Cancer Treat Rep; 1986 Sep; 70(9):1073-9. PubMed ID: 3527407
[TBL] [Abstract][Full Text] [Related]
12. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Yap HY; Buzdar AU; Tashima CK; Burgess MA; Hersh EM
Cancer; 1979 Mar; 43(3):1112-22. PubMed ID: 427716
[TBL] [Abstract][Full Text] [Related]
13. Short-term and long-term effects of chemoimmunotherapy on granulopoiesis: adjuvant therapy of breast cancer.
Lohrmann HP; Schreml W; Lang M
Recent Results Cancer Res; 1982; 80():192-9. PubMed ID: 7058278
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trial.
Jones SE; Salmon SE; Allen H; Giordano GF; Davis S; Chase E; Moon TE; Heusinkveld RS
Recent Results Cancer Res; 1982; 80():162-9. PubMed ID: 7036279
[TBL] [Abstract][Full Text] [Related]
15. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
[TBL] [Abstract][Full Text] [Related]
16. Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial.
Paterson AH; Edwards AM; Nutting M; Schinnour D; Takats L; McClelland A
Cancer Clin Trials; 1980; 3(1):5-10. PubMed ID: 6993035
[TBL] [Abstract][Full Text] [Related]
17. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
Buzdar AU; Gutterman JU; Blumenschein GR; Hortobagyi GN; Tashima CK; Smith TL; Hersh EM; Freireich EJ; Gehan EA
Cancer; 1978 Mar; 41(3):1064-75. PubMed ID: 638948
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
[TBL] [Abstract][Full Text] [Related]
19. Levamisole as adjuvant immunotherapy in breast cancer.
Treurniet-Donker AD; Meischke-de Jongh ML; van Putten WL
Cancer; 1987 May; 59(9):1590-3. PubMed ID: 3828958
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
Rosso R; Boccardo F; Brema F; Sertoli MR; Amoroso D; Bertelli G; Pronzato P
Anticancer Res; 1989; 9(4):1153-6. PubMed ID: 2817796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
